We find ourselves in unusual times. As we struggle with the financial and social challenges that this pandemic brings, I want to reassure our faculty and staff that we remain committed to our cause of advancing cancer care in this state. To that effect, we are pleased to announce two new leaders of our Cancer Immunology research program. See their story below.
We also remain committed to pursuing new hires in our oncology program that we feel are mission-critical to our goals. It is a pleasure serving as interim director and plans are moving forward to vet candidates for our new cancer center director. In the meantime, my door is open to anyone who has questions or concerns.
Please refer to the links at the bottom of this e-newsletter for links to MUHA and MUSC resources that may be of help during this time.
Denis Guttridge, Ph.D.
Hollings Cancer Center Interim Director